The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Open accessAbstract
A unique screen was used to identify mutations in Escherichia coli lipid A biosynthesis that result in a decreased ability to stimulate E-selectin expression by human endothelial cells. A mutation was identified in the msbB gene of E. coli that resulted in lipopolysaccharide (LPS) that lacks the myristoyl fatty acid moiety of the lipid A. Unlike all previously reported lipid A mutants, the msbB mutant was not conditionally lethal for growth. Viable cells or purified LPS from an msbB mutant had a 1000-10,000-fold reduction in the ability to stimulate E-selectin production by human endothelial cells and TNF alpha production by adherent monocytes. The cloned msbB gene was able to functionally complement the msbB mutant, restoring both the LPS to its native composition and the ability of the strain to stimulate immune cells. Nonmyristoylated LPS acted as an antagonist for E-selectin expression when mixed with LPS obtained from the parental strain. These studies demonstrate a significant role for the myristate component of LPS in immune cell activation and antagonism. In addition, the msbB mutant allowed us to directly examine the crucial role that the lipid A structure plays when viable bacteria are presented to host defense cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, hexa-acylated LPS potently activates TLR4 and host immunity, whereas hypo-acylated penta- and tetra-acylated LPS poorly activate TLR4 and can antagonize immune activation by hexa-acylated LPS6–9.”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Yanisch-Perron, C., Vieira, J., & Messing, J. W. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 14,909
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996
[10] Assay of inorganic phosphate, total phosphate and phosphatases
Ames, B. N. (1966) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(66)08014-5 · Cited by 3,338
Westphal, O. (1965) · Medical Entomology and Zoology · Cited by 2,533
Identification of a protein required for disulfide bond formation in vivo.
Bardwell, J., McGovern, K., & Beckwith, J. (1991) · Cell · doi:10.1016/0092-8674(91)90532-4 · Cited by 961
Pugin, J., Schürer-Maly, C., Leturcq, D., Moriarty, A., Ulevitch, R., & Tobias, P. (1993) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.90.7.2744 · Cited by 901
Soluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bažil, V., Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1665 · Cited by 682
A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance
Jorgensen, R. A., Rothstein, S. J., & Reznikoff, W. S. (1979) · Molecular and General Genetics MGG · doi:10.1007/bf00267254 · Cited by 577
Research works printed but not linked: 1
- Takada, H., and S. Kotani. 1992. Structure-function relationships of lipid A. In Bacterial endotoxic lipopolysaccharides. Volume I. Molecular Biochemis- try and Cellular Biology. D. C. Morrison and J. L. Ryan, editors. CRC Press, Boca Raton, FL. 107-130.
Cited by
Sorted by citations
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,371
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 648
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 645
The microbial challenge in periodontitis
Darveau, R. P., Tanner, A. C. R., & Page, R. C. (1997) · Periodontology 2000 · doi:10.1111/j.1600-0757.1997.tb00190.x · Cited by 633
Self-citationHuman Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Regulation of Lipid A Modifications by Salmonella typhimurium Virulence Genes phoP-phoQ
Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., & Miller, S. I. (1997) · Science · doi:10.1126/science.276.5310.250 · Cited by 559
Self-citationDarveau, R. P., Pham, T.-T. T., Lemley, K., Reife, R. A., Bainbridge, B. W., Coats, S. R., Howald, W. N., Way, S. S., & Hajjar, A. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5041-5051.2004 · Cited by 507
Self-citationSpecific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Low, K. B., Ittensohn, M., Le, T. B., Platt, J. T., Sodi, S., Amoss, M. S., Ash, O., Carmichael, E. P., Chakraborty, A. K., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 479
Krisanaprakornkit, S., Kimball, J. R., Weinberg, A., Darveau, R. P., Bainbridge, B. W., & Dale, B. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2907-2915.2000 · Cited by 419
Self-citationOuter membrane vesicles as platform vaccine technology
van der Pol, L., Stork, M., & van der Ley, P. (2015) · Biotechnology Journal · doi:10.1002/biot.201400395 · Cited by 394
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
Chen, W., Wang, Y., Qin, M., Zhang, X., Zhang, Z., Sun, X., & Gu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b02235 · Cited by 386
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Li, M., Zhou, H., Yang, C., Wu, Y., Zhou, X., Liu, H., & Wang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.031 · Cited by 370
Bioengineered and biohybrid bacteria-based systems for drug delivery
Hosseinidoust, Z., Mostaghaci, B., Yaşa, Ö., Park, B.-W., Singh, A. V., & Sitti, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.09.007 · Cited by 366
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J. M., Bermudes, D. G., Brecher, S. M., Margitich, D., Turnier, J. C., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 356
The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis
Erttmann, S. F., Swacha, P., Aung, K. M., Brindefalk, B., Jiang, H., Härtlová, A., Uhlin, B. E., Wai, S. N., & Gekara, N. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.006 · Cited by 358
Zhou, Z., White, K. A., Polissi, A., Georgopoulos, C. P., & Raetz, C. R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12466 · Cited by 346
Caesar, R., Reigstad, C. S., Bäckhed, H. K., Reinhardt, C., Ketonen, M., Östergren‐Lundén, G., Cani, P. D., & Bäckhed, F. (2012) · Gut · doi:10.1136/gutjnl-2011-301689 · Cited by 348
Bacterial lipopolysaccharides and innate immunity
Alexander, C., & Rietschel, E. T. (2001) · Journal of Endotoxin Research · doi:10.1179/096805101101532675 · Cited by 1,206
Metabolic Interdependence of Obligate Intracellular Bacteria and Their Insect Hosts
Zientz, E., Dandekar, T., & Gross, R. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.745-770.2004 · Cited by 311
Bacteria as tumour-targeting vectors
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01194-x · Cited by 291
Bioengineering bacterial outer membrane vesicles as vaccine platform
Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., van der Pol, L., & Stork, M. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.05.003 · Cited by 298
Matsuura, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00109 · Cited by 257
Variation in lipid A structure in the pathogenic yersiniae
Rebeil, R., Ernst, R. K., Gowen, B. B., Miller, S. I., & Hinnebusch, B. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04059.x · Cited by 255
Chemistry of Lipid A: At the Heart of Innate Immunity
Molinaro, A., Holst, O., Lorenzo, F. D., Callaghan, M., Nurisso, A., D’Errico, G., Zamyatina, A., Peri, F., Berisio, R., Jerala, R., et al. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201403923 · Cited by 248
outer membrane remodeling: role in resistance to host innate immunity
Ernst, R. K., Guina, T., & Miller, S. I. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01494-0 · Cited by 238
van der Ley, P., Steeghs, L., Hamstra, H.-J., ten Hove, J., Zomer, B., & van Alphen, L. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.5981-5990.2001 · Cited by 215
A lethal role for lipid A in Salmonella infections
Khan, S. A., Everest, P. H., Servos, S., Foxwell, N., Zähringer, U., Brade, H., Rietschel, E., Dougan, G., Charles, I. G., & Maskell, D. J. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00952.x · Cited by 212
Feng, Q., Ma, X., Cheng, K., Liu, G., Li, Y., Yue, Y., Liang, J., Zhang, L., Zhang, T., Wang, X., et al. (2022) · Advanced Materials · doi:10.1002/adma.202206200 · Cited by 212
Rapid isolation method for lipopolysaccharide and lipid A from Gram-negative bacteria
Yi, E. C., & Hackett, M. (2000) · The Analyst · doi:10.1039/b000368i · Cited by 210
Structural and functional analyses of bacterial lipopolysaccharides
Caroff, M., Karibian, D., Cavaillon, J., & Haeffner‐Cavaillon, N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01612-x · Cited by 210
Complete DNA Sequence and Analysis of the Large Virulence Plasmid of Shigella flexneri
Venkatesan, M. M., Goldberg, M. B., Rose, D. J., Grotbeck, E. J., Burland, V., & Blattner, F. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.3271-3285.2001 · Cited by 210
Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis
Jain, S., & Darveau, R. P. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00333.x · Cited by 203
Self-citationCytokine responses during mucosal infections: role in disease pathogenesis and host defence
Svanborg, C., Godaly, G., & Hedlund, M. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80017-4 · Cited by 203
Clementz, T., Zhou, Z., & Raetz, C. R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10353 · Cited by 199
Clementz, T., Bednarski, J. J., & Raetz, C. R. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12095 · Cited by 188
Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-like Receptor 2
Tükel, Ç., Wilson, R. P., Nishimori, J. H., Pezeshki, M., Chromy, B. A., & Bäumler, A. J. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.020 · Cited by 190
Torrelles, J. B., Azad, A. K., & Schlesinger, L. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1805 · Cited by 182
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S., & Richter-Dahlfors, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00207-7 · Cited by 177
Pelletier, M. R., Casella, L. G., Jones, J. W., Adams, M. D., Zurawski, D. V., Hazlett, K. R. O., Doi, Y., & Ernst, R. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00865-13 · Cited by 175
Escherichia coli P fimbriae utilize the Toll‐like receptor 4 pathway for cell activation
Frendéus, B., Wachtler, C., Hedlund, M., Fischer, H., Samuelsson, P., Svensson, M., & Svanborg, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02361.x · Cited by 172
Binsker, U., Käsbohrer, A., & Hammerl, J. A. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab049 · Cited by 174
Coats, S. R., Pham, T.-T. T., Bainbridge, B. W., Reife, R. A., & Darveau, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4490 · Cited by 169
Self-citationVesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., & Munford, R. S. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2410-2417.2000 · Cited by 168
Factors affecting the escape of Francisella tularensis from the phagolysosome
Lindgren, H., Golovliov, I. R., Baranov, V. I., Ernst, R. K., Telepnev, M., & Sjöstedt, A. B. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45685-0 · Cited by 166
Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjöstedt, A. B., Edebro, H., Forsman, M., Byström, M., Pelletier, M. R., Wilson, C. B., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00934-06 · Cited by 164
Bäckhed, F., Söderhäll, M., Ekman, P., Normark, S. J., & Richter‐Dahlfors, A. (2001) · Cellular Microbiology · doi:10.1046/j.1462-5822.2001.00101.x · Cited by 164
Pharmacological Inhibition of Endotoxin Responses Is Achieved by Targeting the TLR4 Coreceptor, MD-2
Visintin, A., Halmen, K. A., Latz, E., Monks, B. G., & Golenbock, D. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6465 · Cited by 153
The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella
Wilson, R. P., Raffatellu, M., Chessa, D., Winter, S., Tükel, Ç., & Bäumler, A. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01090.x · Cited by 154
Jiang, L., Vader, P., & Schiffelers, R. M. (2017) · Gene Therapy · doi:10.1038/gt.2017.8 · Cited by 153
The Oral Microbial Consortium's Interaction with the Periodontal Innate Defense System
Darveau, R. P. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0864 · Cited by 150
Self-citationHigh Yield Production Process for Shigella Outer Membrane Particles
Scorza, F. B., Colucci, A. M., Maggiore, L., Sanzone, S., Rossi, O., Ferlenghi, I., Pesce, I., Caboni, M., Norais, N., Cioccio, V. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035616 · Cited by 148
Redefining the Requisite Lipopolysaccharide Structure in Escherichia coli
Meredith, T. C., Aggarwal, P., Mamat, U., Lindner, B., & Woodard, R. W. (2006) · ACS Chemical Biology · doi:10.1021/cb0500015 · Cited by 146
D'Hauteville, H., Khan, S. A., Maskell, D. J., Kussak, A., Weintraub, A., Mathison, J. C., Ulevitch, R. J., Wuscher, N., Parsot, C., & Sansonetti, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5240 · Cited by 143
Shield as Signal: Lipopolysaccharides and the Evolution of Immunity to Gram-Negative Bacteria
Munford, R. S., & Varley, A. W. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020067 · Cited by 141
Coats, S. R., Reife, R. A., Bainbridge, B. W., Pham, T.-T. T., & Darveau, R. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.6799-6807.2003 · Cited by 138
Self-citationFischer, H., Ellström, P., Ekström, K., Gustafsson, L., Gustafsson, M. C. U., & Svanborg, C. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00867.x · Cited by 136
Larsen, J. M., Steen-Jensen, D. B., Moll, J. M., Søndergaard, J. N., Musavian, H. S., Butt, T. M., & Brix, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031976 · Cited by 138
Ernst, R. K., Adams, K. N., Moskowitz, S. M., Kraig, G. M., Kawasaki, K., Stead, C. M., Trent, M. S., & Miller, S. I. (2005) · Journal of Bacteriology · doi:10.1128/jb.188.1.191-201.2006 · Cited by 134
A Triple Mutant of Escherichia coli Lacking Secondary Acyl Chains on Lipid A
Vorachek‐Warren, M. K., Kalb, S. R., Cotter, R. J., & Raetz, C. R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200409200 · Cited by 132
Type 1 fimbriae deliver an LPS‐ and TLR4‐dependent activation signal to CD14‐negative cells
Hedlund, M., Frendéus, B., Wachtler, C., Hang, L., Fischer, H., & Svanborg, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02205.x · Cited by 130
Tian, L., White, J. E., Lin, H., Haran, V. S., Sacco, J., Chikkappa, G., Davis, F. B., Davis, P. J., & Tsan, M. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c740 · Cited by 129
Clements, A., Tull, D., Jenney, A. W. J., Farn, J. L., Kim, S., Bishop, R. E., McPhee, J. B., Hancock, R. E. W., Hartland, E. L., Pearse, M. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701454200 · Cited by 124
Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles
Kim, S., Kim, K. S., Lee, S., Kim, E., Kim, M.-S., Lee, E., Gho, Y. S., Kim, J.-W., Bishop, R. E., & Chang, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.08.001 · Cited by 121
Que, N. L. S., Lin, S., Cotter, R. J., & Raetz, C. R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004008200 · Cited by 120
Vaara, M., & Nurminen, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1459 · Cited by 118
Identification of the Gene Encoding the Escherichia coli Lipid A 4′-Kinase
Garrett, T. A., Kadrmas, J. L., & Raetz, C. R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21855 · Cited by 115
Zhang, C., Han, K., Chandler, C. E., Tjaden, B. C., Ernst, R. K., & Lory, S. J. (2017) · Molecular Microbiology · doi:10.1111/mmi.13857 · Cited by 114
Irene, C., Fantappiè, L., Caproni, E., Zerbini, F., Anesi, A., Tomasi, M., Zanella, I., Stupia, S., Prete, S., Valensin, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905112116 · Cited by 111
P fimbriae‐dependent, lipopolysaccharide‐independent activation of epithelial cytokine responses
Hedlund, M., Wachtler, C., Johansson, E., Hang, L. M., Somerville, J. E., Darveau, R. P., & Svanborg, C. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01513.x · Cited by 109
Self-citationAntibacterial and anti-inflammatory agents that target endotoxin
Wyckoff, T. J. O., Raetz, C. R. H., & Jackman, J. E. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01230-x · Cited by 107
Henderson, B. E., Calderwood, S. K., Coates, A. R. M., Cohen, I. R., van Eden, W., Lehner, T., & Pockley, A. G. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-009-0137-6 · Cited by 109
Halaby, T., Küçükköse, E., Janssen, A. B., Rogers, M. R. C., Doorduijn, D. J., van der Zanden, A. G. M., al Naiemi, N., Vandenbroucke‐Grauls, C. M. J. E., & van Schaik, W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01344-16 · Cited by 105
Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation
Gioannini, T. L., Teghanemt, A., Zhang, D., Levis, E. N., & Weiss, J. P. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35198 · Cited by 105
Tajer, L., Paillart, J., Dib, H., Sabatier, J., Fajloun, Z., & Khattar, Z. A. (2024) · Microorganisms · doi:10.3390/microorganisms12071259 · Cited by 109
Rebeil, R., Ernst, R. K., Jarrett, C. O., Adams, K. N., Miller, S. I., & Hinnebusch, B. J. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.4.1381-1388.2006 · Cited by 104
Rossi, O., Pesce, I., Giannelli, C., Aprea, S., Caboni, M., Citiulo, F., Valentini, S. B., Ferlenghi, I., MacLennan, C. A., D’Oro, U., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566570 · Cited by 102
Escherichia coli msbB Gene as a Virulence Factor and a Therapeutic Target
Somerville, J. E., Cassiano, L., & Darveau, R. P. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6583-6590.1999 · Cited by 101
Self-citationLapaque, N., Takeuchi, O., Corrales, F. J., Akira, S., Moriyón, I., Howard, J. C., & Gorvel, J. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00629.x · Cited by 100
Coats, S. R., Berezow, A. B., To, T. T., Jain, S., Bainbridge, B. W., Banani, K. P., & Darveau, R. P. (2010) · Infection and Immunity · doi:10.1128/iai.00937-10 · Cited by 97
Self-citationVorachek‐Warren, M. K., Carty, S. M., Lin, S., Cotter, R. J., & Raetz, C. R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200408200 · Cited by 96
Invited review: Lipopolysaccharide biosynthesis: which steps do bacteria need to survive?
Gronow, S., & Brade, H. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070010301 · Cited by 95
Tran, A. X., Lester, M. E., Stead, C. M., Raetz, C. R. H., Maskell, D. J., McGrath, S. C., Cotter, R. J., & Trent, M. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505020200 · Cited by 94
Invasion of bone cells by Staphylococcus epidermidis
Khalil, H. S., Williams, R. J., Stenbeck, G., Henderson, B. E., Meghji, S., & Nair, S. P. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.01.002 · Cited by 89
Bloor, A. E., & Cranenburgh, R. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2520-2525.2006 · Cited by 88
Boerlin, P., Chen, S., Colbourne, J. K., Johnson, R. P., Grandis, S. D., & Gyles, C. L. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2553-2561.1998 · Cited by 86
Lu, M., Varley, A. W., Ohta, S., Hardwick, J., & Munford, R. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.009 · Cited by 85
Berezow, A. B., Ernst, R. K., Coats, S. R., Braham, P. H., Karimi-Naser, L. M., & Darveau, R. P. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.04.015 · Cited by 84
Self-citationAll blood, No stool: enterohemorrhagic Escherichia coli O157:H7 infection
Yoon, J. W., & Hovde, C. J. (2008) · Journal of Veterinary Science · doi:10.4142/jvs.2008.9.3.219 · Cited by 81
Novem, V., Shui, G., Wang, D., Bendt, A. K., Sim, S. H., Liu, Y., Thong, T. W., Sivalingam, S. P., Ooi, E. E., Wenk, M. R., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00472-08 · Cited by 81
Kawasaki, K., Ernst, R. K., & Miller, S. I. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2448-2457.2005 · Cited by 79
Activation of Toll-like Receptor 4 on Tumor Cells In vitro Inhibits Subsequent Tumor Growth In vivo
Andreani, V., Gatti, G., Simonella, L. E., Rivero, V. E., & Maccioni, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0079 · Cited by 85
Lambrianides, A., Carroll, C. J., Pierangeli, S. S., Pericleous, C., Branch, W. D., Rice, J., Latchman, D. S., Townsend, P. A., Isenberg, D. A., Rahman, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902765 · Cited by 78
Kim, J. H., Yoon, Y. J., Lee, J., Choi, E.-J., Yi, N., Park, K., Park, J., Lötvall, J. O., Kim, Y., & Gho, Y. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059276 · Cited by 80
Kanipes, M. I., Lin, S., Cotter, R. J., & Raetz, C. R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009019200 · Cited by 78
Shaffer, S. A., Harvey, M. D., Goodlett, D. R., & Ernst, R. K. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.03.008 · Cited by 78
Neutrophils use superoxide to control bacterial infection at a distance
Phan, Q. T., Sipka, T., Gonzalez, C., Levraud, J., Lutfalla, G., & Chi, M. N. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007157 · Cited by 76
A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles
Leitner, D. R., Lichtenegger, S., Temel, P., Zingl, F. G., Ratzberger, D., Roier, S., Schild-Prüfert, K., Feichter, S., Reidl, J., & Schild, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00823 · Cited by 75
Thiéblemont, N., Thieringer, R., & Wright, S. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80582-8 · Cited by 75
Metadata
- Authors
- Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P.
- Affiliations
- Bristol-Myers Squibb (United States) (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-01-15
- Volume
- 97
- Issue
- 2
- Pages
- 359-365
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507025
- OpenAlex
- W2006697711
- Cited by
- 275
- References
- 31
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 8 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 10 · 2016: 5 · 2015: 6 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Escherichia coli, lipid A, lipopolysaccharide biosynthesis, E-selectin, endothelial cells, TNF-α, monocytes, immune cell activation, complementation
- MeSH terms
- Acyltransferases, Cells, Cultured, Endothelium, Vascular, Escherichia coli, Fatty Acids, Humans, Isomerases, Lipid A, Lipopolysaccharides, Myristic Acids, Structure-Activity Relationship, Tumor Necrosis Factor-alpha, Mutagenesis, E-Selectin, Protein Disulfide-Isomerases, Myristic Acid, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review